Experimental design in methotrexate efficacy studies for rheumatoid arthritis

    Research output: Other contributionOther research output

    Abstract

    When developing new medication for rheumatoid arthritis (RA), complementary animal models are used to predict clinical effects. These models cause substantial discomfort to the experimental animals. It is unknown how effective the animal models are in predicting clinical efficacy.

    The clinical trials and animal studies for the classical disease-modifying anti-rheumatic drugs (DMARDs) are accepted as a viable research tool. Methotrexate is a widely used DMARD. Presently a clear overview of the used experimental designs and the differences between designs in clinical trials and animal studies is lacking. It will be provided by this SR.
    Original languageEnglish
    TypeProtocol
    Media of outputWebsite
    Number of pages7
    Place of Publicationwww.syrcle.nl
    Publication statusPublished - 19 Feb 2016

    Fingerprint

    Dive into the research topics of 'Experimental design in methotrexate efficacy studies for rheumatoid arthritis'. Together they form a unique fingerprint.

    Cite this